Oncology
1 drug is in development for Glioma, Malignant.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Glioma, Malignant pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| TNG456 | Tango Therapeutics, Inc. (TNGX) |
About this indication
Glioma, Malignant context
Oncology·MeSH: Glioma (D005910)
Narrower concept of MeSH descriptor Glioma
Frequently asked questions
How many drugs are in development for Glioma, Malignant?
BioSniper tracks 1 drug in development for Glioma, Malignant across 1 company.
How many clinical trials target Glioma, Malignant?
There are 6 clinical trials targeting Glioma, Malignant tracked by BioSniper.